Is Alexion Pharmaceuticals, Inc. (ALXN) Stock Worth a Buy Wednesday?

Wednesday, July 14, 2021 10:38 AM | InvestorsObserver Analysts

Mentioned in this article

Is Alexion Pharmaceuticals, Inc. (ALXN) Stock Worth a Buy Wednesday?

Alexion Pharmaceuticals, Inc. (ALXN) stock has gained 72.33% over the last 12 months, and the average rating from Wall Street analysts is a Hold. *InvestorsObserver’s* proprietary ranking system, gives ALXN stock a score of 82 out of a possible 100. That rank is chiefly influenced by a short-term technical score of 90. ALXN's rank also includes a long-term technical score of 86. The fundamental score for ALXN is 69. In addition to the average rating from Wall Street analysts, ALXN stock has a mean target price of 166.846. This means analysts expect the stock to decline 10.83% over the next 12 months.

ALXN has an Overall Score of 82. Find out what this means to you and get the rest of the rankings on ALXN!

See Full ALXN Report

## What's Happening with ALXN Stock Today Alexion Pharmaceuticals, Inc. (ALXN) stock has risen 0.6% while the S&P 500 has gained 0.41% as of 10:34 AM on Wednesday, Jul 14. ALXN has gained $1.12 from the previous closing price of $185.98 on volume of 2,301,590 shares. Over the past year the S&P 500 is higher by 37.20% while ALXN has gained 72.33%. ALXN earned $3.05 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 61.46. Click Here to get the full Stock Report for Alexion Pharmaceuticals, Inc. stock.